How mental health care should change as a consequence of the COVID-19 pandemicCarmen Moreno, Celso Arango, Christoph U. Correll et al.|The Lancet Psychiatry|2020Cited by 1.9k
Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and TherapeuticsJeffrey A. Lieberman|Neuropsychopharmacology|2005Cited by 162
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaTristram A. Lett, Aristotle N. Voineskos, M M Chakavarty et al.|Molecular Psychiatry|2013Cited by 119
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-AnalysisEric Yi‐Hsiu Huang, James Kennedy, Clement C. Zai et al.|The International Journal of Neuropsychopharmacology|2016Cited by 64